MedPath

Safety and Acceptability of Using a Rewetting Drop With Contact Lens Wear

Phase 2
Completed
Conditions
Ametropia
Registration Number
NCT00691197
Lead Sponsor
Allergan
Brief Summary

Testing the Safety and Acceptability of Using a Rewetting Drop with Contact Lenses

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
246
Inclusion Criteria
  • Adapted contact lens wearer
Exclusion Criteria
  • Monovision lens wearer, ocular or systemic disease, pregnant or planning to become pregnant

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Best Corrected Visual AcuityChange from Baseline at Day 90

Percentage of Subjects Tabulated by Changes in Line Number at Day 90 from Baseline; Visual Acuity measured by LogMar reported as Snellen equivalents. Better: an increase of 2 lines or more in at least one eye; No Change: a change less than +/- 2 lines in both eyes; Worse: a decrease of 2 lines or more in at least one eye.

Secondary Outcome Measures
NameTimeMethod
Corneal StainingDay 90

Corneal staining of greater or equal to grade 2 at day 90. Grading scale: 0 = None Present; 1 = Trace Finding; 2 = Mild Finding; 3 = Moderate Finding; 4 = Severe Finding

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.